{"SLR NAME":"Venovenous extracorporeal membrane oxygenation for COVID-19 patients with severe acute respiratory distress syndrome: a systematic review and meta-analysis","References":[{"title1":"SARS-CoV-2 and ECMO: early results and experience","References":[{"title2":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.10.1016/S0140-6736(20)30566-3.","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study [published online ahead of print, 2020 Aug 13]","References":[{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"Extracorporeal membrane oxygenation for coronavirus disease 2019-induced acute respiratory distress syndrome: a multicenter descriptive study"},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 disease is suspected"},{"title3":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)"},{"title3":"Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: any impact on their outcomes?"},{"title3":"Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective single center cohort study"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Severe pulmonary embolism in COVID-19 patients: a call for increased awareness"},{"title3":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort"},{"title3":"Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine"},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score"},{"title3":"Ventilator-related causes of lung injury: the mechanical power"},{"title3":"Physiologic analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome"},{"title3":"Tutorial in biostatistics: competing risks and multi-state models"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Formal guidelines: management of acute respiratory distress syndrome"},{"title3":"Extracorporeal life support for adults with respiratory failure and related indications: a review"},{"title3":"Driving pressure and survival in the acute respiratory distress syndrome"},{"title3":"Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis"},{"title3":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence"},{"title3":"Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock"}]},{"title2":"Mustafa AK, Alexander PJ, Joshi DJ, et al. Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg. Published online August. 2020;11:990. 10.1001/jamasurg.2020.3950.","References":[]},{"title2":"Gandhi RT, Lynch JB, Del Rio C. Mild or moderate COVID-19 [published online ahead of print, 2020 Apr 24]. N Engl J Med. 2020. 10.1056/NEJMcp2009249.","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review [published online ahead of print, 2020 Jul 10]. JAMA. 2020. 10.1001/jama.2020.12839.","References":[]},{"title2":"COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review","References":[{"title3":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak"},{"title3":"China Medical Treatment Expert Group for Covid-19, Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Coronavirus Disease 2019 (COVID-19): A Perspective from China"},{"title3":"Fleischner Society: Glossary of Terms for Thoracic Imaging"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study"},{"title3":"CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China"},{"title3":"Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection"},{"title3":"Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2"},{"title3":"Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management"},{"title3":"Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases"},{"title3":"The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia"},{"title3":"Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes"},{"title3":"Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT"},{"title3":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias"},{"title3":"Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China"},{"title3":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review"},{"title3":"Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia"},{"title3":"Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia"},{"title3":"Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia?"},{"title3":"Findings of lung ultrasonography of novel corona virus pneumonia during the 2019 - 2020 epidemic"},{"title3":"Coronavirus (COVID-19) events as they happen (n.d.). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen (Accessed 20 March 2020)."},{"title3":"Situation Report-59 HIGHLIGHTS (n.d.) https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200319-sitrep-59-covid-19.pdf?sfvrsn=c3dcdef9_2 (Accessed 20 March 2020)."},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?"},{"title3":"Acute pulmonary injury: High-resolution CT and histopathological spectrum"}]},{"title2":"Bustin SA, Nolan T. RT-qPCR testing of SARS-CoV-2: a primer. Int J Mol Sci. 2020;21:3004.","References":[]},{"title2":"Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. Published 2020 May 22. 10.1136/bmj.m1985.","References":[]},{"title2":"Berlin DA, Gulick RM, Martinez FJ. Severe COVID-19 [published online ahead of print, 2020 May 15]. N Engl J Med. 2020. 10.1056/NEJMcp2009575.","References":[]},{"title2":"Risk factors for death from COVID-19","References":[]},{"title2":"Intensive Care national audit and research centre. ICNARC report on COVID-19 in critical care. England. Intensive Care national audit and research centre. 2020 June 5 [cited 2020 June 5] Available at https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports (last checked 2/08/2020)","References":[]},{"title2":"Specialised Commissioning Team NHS England. Clinical Commissioning Policy: Extra corporeal membrane oxygenation (ECMO) service for adults with cardiac failure 16028/P. England. NHS England. 2016 July 13 [Cited 2020 August 2]. Available from: https://www.england.nhs.uk/wp-content/uploads/2018/07/Extra-corporeal-membrane-oxygenation-service-for-adults-with-cardiac-failure.pdf","References":[]},{"title2":"Warren A, Camporota L, Vuylsteke A. Surge capacity and updated admission criteria: response of the NHS-commissioned national respiratory extracorporeal membrane oxygenation network to the COVID-19 pandemic. Br J Anaesth. 2020; 10.1016/j.bja.2020.06.008.","References":[]},{"title2":"Barts' Health NHS Trust. About us. England. Barts Health NHS Trust. 2020 [cited 2020 August 2]. Available from: https://www.bartshealth.nhs.uk/about-us.","References":[]},{"title2":"Kurihara C, Walter JM, Karim A, et al. Feasibility of venovenous extracorporeal membrane oxygenation without systemic anticoagulation. Ann Thor Surg. 2020; 10.1016/j.athoracsur.2020.02.011.","References":[]},{"title2":"Faculty of Intensive Care Medicine. ViRUS 1: Poor ventilation occurred in patients who were mechanically ventilated using a dry circuit with HME filters in place between catheter mount and rest of circuit, due to clogging in the HME filter. England. Faculty of Intensive Care Medicine. 2020 April 1 [cited 2020 August 2] https://www.ficm.ac.uk/sites/default/files/virus1_0.pdf.","References":[]},{"title2":"Routine CT scanning of patients retrieved to a tertiary centre on veno-venous extracorporeal membrane oxygenation: a retrospective risk benefit analysis","References":[]},{"title2":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","References":[]},{"title2":"Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: a systematic and narrative review","References":[{"title3":"Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007"},{"title3":"Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012"},{"title3":"Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011"},{"title3":"Neurologic complications of extracorporeal membrane oxygenation"},{"title3":"Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock"},{"title3":"Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study"},{"title3":"Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation"},{"title3":"Clinical review: extracorporeal membrane oxygenation"},{"title3":"Extracorporeal membrane oxygenation for respiratory failure in adults"},{"title3":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome"},{"title3":"Neurologic complications of extracorporeal membrane oxygenation: a review"},{"title3":"Evaluation of the Endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses"},{"title3":"Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study"},{"title3":"Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation"},{"title3":"Neurologic injury with severe adult respiratory distress syndrome in patients undergoing extracorporeal membrane oxygenation"},{"title3":"Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage"},{"title3":"Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the extracorporeal life support organization database"},{"title3":"In-Hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support organization registry"},{"title3":"Brain injury during venovenous extracorporeal membrane oxygenation"},{"title3":"Duration of ECMO is an independent predictor of intracranial hemorrhage occurring during ECMO support"},{"title3":"Extracorporeal life support organization registry report 2012"},{"title3":"Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years"},{"title3":"Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): an observational cohort study"},{"title3":"Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO)"},{"title3":"The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks"},{"title3":"Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation"},{"title3":"Cerebral microbleeds after use of extracorporeal membrane oxygenation in children"},{"title3":"Diffuse cerebral microbleeds after extracorporeal membrane oxygenation support"},{"title3":"Neurological injury in adults treated with extracorporeal membrane oxygenation"},{"title3":"Cranial CT for diagnosis of intracranial complications in adult and pediatric patients during ECMO: clinical benefits in diagnosis and treatment"},{"title3":"Intrahospital transport of critically ill patients: complications and difficulties"},{"title3":"Secondary insults during intrahospital transport of head-injured patients"},{"title3":"Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy"},{"title3":"Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy"},{"title3":"Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS)"},{"title3":"Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation"},{"title3":"Coagulation parameter instability as an early predictor of intracranial hemorrhage during extracorporeal membrane oxygenation"},{"title3":"Extracorporeal membrane oxygenation in the adult"},{"title3":"Systemic consequences of ventricular assist devices: alterations of coagulation, immune function, inflammation, and the neuroendocrine system"},{"title3":"Anticoagulation and transfusion therapy in patients requiring extracorporeal membrane oxygenation"},{"title3":"Roller and centrifugal pumps: a retrospective comparison of bleeding complications in extracorporeal membrane oxygenation"},{"title3":"Outcome in patients with H1N1 influenza and cerebrovascular injury treated with extracorporeal membrane oxygenation"},{"title3":"Neurocognitive outcomes after extracorporeal membrane oxygenation"},{"title3":"The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model"},{"title3":"Physiology of cerebral blood flow"},{"title3":"Regulation of cerebral autoregulation by carbon dioxide"},{"title3":"Optimizing sedation in patients with acute brain injury"},{"title3":"Effects of venovenous extracorporeal membrane oxygenation on cerebral oxygenation in hypercapnic ARDS"},{"title3":"Cerebral tissue oxygenation during the initiation of venovenous ECMO"},{"title3":"The effect of extracorporeal life support on the brain: a focus on ECMO"},{"title3":"Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO"},{"title3":"Mechanisms of change in cardiac performance in infants undergoing extracorporeal membrane oxygenation"},{"title3":"Veno-venous extracorporeal membrane oxygenation: anesthetic management for massive intracranial hemorrhage in H1N1 infection"},{"title3":"Intracranial hemorrhage surgery on patients on mechanical circulatory support: a case series"},{"title3":"Craniotomy during ECMO in a severely traumatized patient"},{"title3":"Surgical treatment of intraparenchymal hemorrhage during mechanical circulatory support for heart-failure - a single-centre experience"},{"title3":"Prolonged venovenous extracorporeal membrane oxygenation without anticoagulation: a case of Goodpasture syndrome-related pulmonary haemorrhage"},{"title3":"Non-heparinized ECMO serves a rescue method in a multitrauma patient combining pulmonary contusion and nonoperative internal bleeding: a case report and literature review"},{"title3":"Case 13 - 2014: management of pulmonary hemorrhage after pulmonary endarterectomy with venovenous extracorporeal membrane oxygenation without systemic anticoagulation"},{"title3":"Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury"},{"title3":"Extracorporeal membrane oxygenation resuscitation for traumatic brain injury after decompressive craniotomy"},{"title3":"Extracorporeal membrane oxygenation support as a life-saving measure for acute respiratory distress syndrome after craniectomy"},{"title3":"ECMO support for right main bronchial disruption in multiple trauma patient with brain injury : a case report and literature review"},{"title3":"Low-dose heparin during extracorporeal membrane oxygenation treatment in adults"},{"title3":"A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk"},{"title3":"Venovenous extracorporeal membrane oxygenation with prophylactic subcutaneous anticoagulation only: an observational study in more than 60 patients"},{"title3":"Low-dose heparin in critically ill patients undergoing extracorporeal membrane oxygenation - the help-ECMO pilot randomised controlled trial"},{"title3":"Platelet dysfunction in patients with severe traumatic brain injury"},{"title3":"Assessment of platelet function in traumatic brain injury:a retrospective observational study in the neuro-critical care setting"},{"title3":"Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry"},{"title3":"An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study"},{"title3":"Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review"},{"title3":"The utility of near infrared spectroscopy in detecting intracranial hemorrhage in children"},{"title3":"Ultrasound non-invasive measurement of intracranial pressure in neurointensive care: a prospective observational study"},{"title3":"Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury"},{"title3":"Kinetic modelling of serum S100b after traumatic brain injury"},{"title3":"A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury"},{"title3":"Validation of the Scandinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults"},{"title3":"Elevated S100B protein as an early indicator of intracranial haemorrhage in infants subjected to extracorporeal membrane oxygenation"},{"title3":"Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO)"},{"title3":"Plasma biomarkers of brain injury as diagnostic tools and outcome predictors after extracorporeal membrane oxygenation"},{"title3":"Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation"},{"title3":"Neuron-specific enolase serum levels predict severe neuronal injury after extracorporeal life support in resuscitation"},{"title3":"Neuromonitoring in the neonatal ECMO patient"},{"title3":"Prognostic value of cerebral tissue oxygen saturation during neonatal extracorporeal membrane oxygenation"},{"title3":"Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation"},{"title3":"Extracorporeal membrane oxygenation and cerebral blood flow velocity in children"},{"title3":"Subarachnoid hemorrhage: who dies, and why?"},{"title3":"The ICH score: a simple, reliable grading scale for intracerebral hemorrhage"},{"title3":"Predictors of 30-day mortality in patients with spontaneous primary intracerebral hemorrhage"}]},{"title2":"The RECOVERY collaborative group. Dexamethasone in hospitalised patients with COVID-19- preliminary report. New England Journal of Medicine (online First) July 17. 2020. 10.1056/NEJMoa2021436.","References":[]}]},{"title1":"Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry","References":[{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","References":[]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial","References":[]},{"title2":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis","References":[]},{"title2":"Clinical management of COVID-19: interim guidance","References":[]},{"title2":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China."},{"title3":"Conflicts of interest disclosure forms and management in critical care clinical practice guidelines."},{"title3":"Understanding conflicts of interest."},{"title3":"GRADE guidelines: 2. Framing the question and deciding on important outcomes."},{"title3":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers."},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations."},{"title3":"GRADE guidelines: 3. Rating the quality of evidence."},{"title3":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations."},{"title3":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes."},{"title3":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT."},{"title3":"Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks."},{"title3":"Control measures for severe acute respiratory syndrome (SARS) in Taiwan."},{"title3":"Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure."},{"title3":"SARS: ventilatory and intensive care."},{"title3":"Particle removal efficiency of the portable HEPA air cleaner in a simulated hospital ward."},{"title3":"Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis."},{"title3":"N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial."},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial."},{"title3":"A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers."},{"title3":"Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers."},{"title3":"A randomized clinical trial of three options for N95 respirators and medical masks in health workers."},{"title3":"Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis."},{"title3":"Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic."},{"title3":"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature."},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review."},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation: a Cochrane Systematic Review."},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation."},{"title3":"Should the Glidescope video laryngoscope be used first line for all oral intubations or only in those with a difficult airway? A review of current literature."},{"title3":"Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia."},{"title3":"Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests."},{"title3":"Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus."},{"title3":"Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China."},{"title3":"Laboratory diagnosis of SARS."},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China."},{"title3":"Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis."},{"title3":"Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids?"},{"title3":"Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis."},{"title3":"Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial."},{"title3":"Lower versus higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis."},{"title3":"Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis."},{"title3":"Mortality after fluid bolus in African children with severe infection."},{"title3":"Colloids versus crystalloids for fluid resuscitation in critically ill people."},{"title3":"Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children."},{"title3":"Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure."},{"title3":"Vasopressors for hypotensive shock."},{"title3":"Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock."},{"title3":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis."},{"title3":"Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock."},{"title3":"Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial."},{"title3":"Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure."},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis."},{"title3":"Corticosteroid therapy for sepsis: a clinical practice guideline."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"The Search for Optimal Oxygen Saturation Targets in Critically Ill Patients: Observational Data From Large ICU Databases."},{"title3":"Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis."},{"title3":"Oxygen therapy for acutely ill medical patients: a clinical practice guideline."},{"title3":"Conservative Oxygen Therapy during Mechanical Ventilation in the ICU."},{"title3":"Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome."},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure."},{"title3":"The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis."},{"title3":"Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials."},{"title3":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis."},{"title3":"Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada."},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation."},{"title3":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial."},{"title3":"Staff safety during emergency airway management for COVID-19 in Hong Kong."},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome."},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection."},{"title3":"Noninvasive Oxygenation Strategies in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials."},{"title3":"Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis."},{"title3":"Noninvasive versus invasive mechanical ventilation for immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis."},{"title3":"Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review."},{"title3":"Noninvasive ventilation for patients with hypoxemic acute respiratory failure."},{"title3":"Ventilator-induced lung injury."},{"title3":"Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features."},{"title3":"Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease."},{"title3":"Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure."},{"title3":"Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask."},{"title3":"Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome."},{"title3":"A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial."},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome."},{"title3":"Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients."},{"title3":"Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome."},{"title3":"(The application of low tidal volume pressure-controlled ventilation in patients with acute respiratory distress syndrome)."},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome."},{"title3":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016."},{"title3":"Patient-ventilator asynchrony during assisted mechanical ventilation."},{"title3":"Optimal plateau pressure for patients with acute respiratory distress syndrome: a protocol for a systematic review and meta-analysis with meta-regression."},{"title3":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome."},{"title3":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial."},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis."},{"title3":"Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis."},{"title3":"Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Comparison of two fluid-management strategies in acute lung injury."},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study."},{"title3":"Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome."},{"title3":"The prone position eliminates compression of the lungs by the heart."},{"title3":"Lung ventilation and perfusion in prone and supine postures with reference to anesthetized and mechanically ventilated healthy volunteers."},{"title3":"Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Prone position for acute respiratory failure in adults."},{"title3":"The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis."},{"title3":"The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: updated study-level meta-analysis of 11 randomized controlled trials."},{"title3":"Enteral feeding in the critically ill: comparison between the supine and prone positions: a prospective crossover study in mechanically ventilated patients."},{"title3":"Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines."},{"title3":"Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient."},{"title3":"New UK guidelines for the management of adult patients with ARDS."},{"title3":"Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome."},{"title3":"Formal guidelines: management of acute respiratory distress syndrome."},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials."},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome."},{"title3":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults."},{"title3":"Lung recruitment in patients with the acute respiratory distress syndrome."},{"title3":"Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial."},{"title3":"Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: a multicenter randomized controlled clinical trial."},{"title3":"Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome."},{"title3":"Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). A Phase II, Multicenter Randomized Controlled Clinical Trial."},{"title3":"Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome."},{"title3":"Lung Recruitment Maneuvers for Adult Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus."},{"title3":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome."},{"title3":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial."},{"title3":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis."},{"title3":"Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation."},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome."},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression."},{"title3":"Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China."},{"title3":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza."},{"title3":"Pharmacological agents for adults with acute respiratory distress syndrome."},{"title3":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial."},{"title3":"Effect of Intravenous Interferon beta-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China."},{"title3":"Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis."},{"title3":"Reevaluating the Role of Corticosteroids in Septic Shock: An Updated Meta-Analysis of Randomized Controlled Trials."},{"title3":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome."},{"title3":"Systemic Corticosteroid Therapy May Delay Viral Clearance in Patients with Middle East Respiratory Syndrome Coronavirus Infection."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients."},{"title3":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa."},{"title3":"Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study."},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States."},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States."},{"title3":"Do specific virus-bacteria pairings drive clinical outcomes of pneumonia?"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis,"},{"title3":"The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study."},{"title3":"Acetaminophen for Fever in Critically Ill Patients with Suspected Infection."},{"title3":"Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group."},{"title3":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group."},{"title3":"Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling."},{"title3":"Effects of lornoxicam on the physiology of severe sepsis."},{"title3":"Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults."},{"title3":"Fever control using external cooling in septic shock: a randomized controlled trial."},{"title3":"Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial."},{"title3":"Body temperature control in patients with refractory septic shock: too much may be harmful."},{"title3":"Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial."},{"title3":"Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial."},{"title3":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study."},{"title3":"Adverse effects of human immunoglobulin therapy."},{"title3":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial."},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection."},{"title3":"The convalescent sera option for containing COVID-19."},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection."},{"title3":"SARS: systematic review of treatment effects."},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection."},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Successful treatment of avian influenza with convalescent plasma."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis."},{"title3":"Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia."},{"title3":"Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea."},{"title3":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial."},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset."},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial."},{"title3":"Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection."},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection."},{"title3":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics."},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin."},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques."},{"title3":"Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)."},{"title3":"Of chloroquine and COVID-19."},{"title3":"Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection."},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies."},{"title3":"(Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia)."},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19."},{"title3":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial."},{"title3":"Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes."},{"title3":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial."},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome."},{"title3":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients."},{"title3":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials."},{"title3":"Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials."},{"title3":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial."},{"title3":"Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness."}]},{"title2":"Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure","References":[]},{"title2":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation","References":[]},{"title2":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","References":[]},{"title2":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports","References":[{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan"}]},{"title2":"SARS-CoV-2 registry addendum database definitions","References":[]},{"title2":"The Extracorporeal Life Support Organization Registry: update and perspectives","References":[]},{"title2":"An empirical transition matrix for non-homogeneous markov chains based on censored observations","References":[]},{"title2":"Estimates of absolute cause-specific risk in cohort studies","References":[]},{"title2":"A note on quantifying follow-up in studies of failure time","References":[]},{"title2":"Nonparametric estimation from incomplete observations","References":[]},{"title2":"The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A position paper of the Extracorporeal Life Support Organization","References":[{"title3":"Conrad SA, Broman LM, Taccone FS, Lorusso R, Malfertheiner MV, Pappalardo F, et al. The Extracorporeal Life Support Organization Maastricht Treaty for nomenclature in extracorporeal life support: a position paper of the Extracorporeal Life Support Organization. Am J Respir Crit Care Med. 2018. 10.1164/rccm.201710-2130CP."},{"title3":"Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung"},{"title3":"Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study"},{"title3":"UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet 1996;348(9020):75-82."},{"title3":"Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis"},{"title3":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial"},{"title3":"Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry"},{"title3":"Image guided placement of extracorporeal life support through bi-caval dual lumen venovenous membrane oxygenation in an interventional radiology setting--initial experience"},{"title3":"Cannula design and recirculation during venovenous extracorporeal membrane oxygenation"},{"title3":"Hybrid configurations via percutaneous access for extracorporeal membrane oxygenation: a single-center experience"},{"title3":"A simple technique of distal limb perfusion during prolonged femoro-femoral cannulation"},{"title3":"Venous leg congestion treated with distal venous drainage during peripheral extracorporeal membrane oxygenation"},{"title3":"Proximal and distal cannulation of the internal jugular vein for ECMO in a primate"},{"title3":"Extracorporeal Life Support Organization Registry. Venovenous extracorporeal membrane oxygenation in neonatal respiratory failure: does routine, cephalad jugular drainage improve outcome?"},{"title3":"Percutaneous left-heart decompression during extracorporeal membrane oxygenation: an alternative to surgical and transeptal venting in adult patients"},{"title3":"Kim HE, Jung JW, Shin YR, Park HK, Park YH, Shin HJ. Left atrial decompression by percutaneous left atrial venting cannula insertion during venoarterial extracorporeal membrane oxygenation support. Korean J Thorac Cardiovasc Surg. 2016;49:203-6."},{"title3":"First-in-man fully percutaneous complete bypass of heart and lung"},{"title3":"Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure"},{"title3":"Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review"},{"title3":"Superior vena cava drainage improves upper body oxygenation during veno-arterial extracorporeal membrane oxygenation in sheep"},{"title3":"Venous cannula positioning in arterial deoxygenation during veno-arterial extracorporeal membrane oxygenation-a simulation study and case report"},{"title3":"Position of draining venous cannula in extracorporeal membrane oxygenation for respiratory and respiratory/circulatory support in adult patients"},{"title3":"Subclavian artery cannulation for venoarterial extracorporeal membrane oxygenation"},{"title3":"The &quot;sport model&quot;: extracorporeal membrane oxygenation using the subclavian artery"},{"title3":"The &quot;central sport model&quot;: extracorporeal membrane oxygenation using the innominate artery for smaller patients as bridge to lung transplantation"}]},{"title2":"Mice: multivariate imputation by chained equations in R","References":[]},{"title2":"A package for survival analysis in S; 2015. Version 2.38","References":[]},{"title2":"cmprsk: subdistribution analysis of competing risks; 2010. R package version 2.2-1","References":[{"title3":"Competing risk regression models for epidemiologic data"},{"title3":"Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests"},{"title3":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators"},{"title3":"The use and interpretation of competing risks regression models"},{"title3":"A nonidentifiability aspect of the problem of competing risks"},{"title3":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations"},{"title3":"Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring"},{"title3":"Regression models and life-tables"},{"title3":"A proportional hazards model for the subdistribution of a competing risk"},{"title3":"A class of K-sample tests for comparing the cumulative incidence of a competing risk"},{"title3":"Therneau TM. A Package for Survival Analysis in S. version 2.40-1. 2016. https://CRAN.R-project.org/package=survival."},{"title3":"Gray B. cmprsk: Subdistribution Analysis of Competing Risks. R package version 2.2-7. 2014. https://CRAN.R-project.org/package=cmprsk."},{"title3":"Pseudo-observations for competing risks with covariate dependent censoring"},{"title3":"R Core Team. R: A Language and Environment for Statistical Computing, Vienna, Austria; 2015. https://www.R-project.org/."},{"title3":"mstate: An R package for the analysis of competing risks and multi-state models"},{"title3":"Putter H, de Wreede L, Fiocco M. mstate: Data Preparation, Estimation and Prediction in Multi-state Models. 2016. R package version 0.2.10. https://CRAN.R-project.org/package=mstate."},{"title3":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia"},{"title3":"Analyses of cumulative incidence functions via non-parametric multiple imputation"},{"title3":"Sensitivity analysis for informative censoring in parametric survival models"},{"title3":"Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?"},{"title3":"Applying k-sample tests to conditional probabilities for competing risks in a clinical trial"},{"title3":"Estimating ethnic differences in self-reported new use of antidepressant medications: results from the multi-ethnic study of atherosclerosis"},{"title3":"Making sense of clinical trial data: Is inverse probability of censoring weighted analysis the answer to crossover bias?"}]},{"title2":"ECMO for ARDS due to COVID-19","References":[]},{"title2":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","References":[]},{"title2":"Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry","References":[]},{"title2":"Assessment of therapeutic interventions and lung protective ventilation in patients with moderate to severe acute respiratory distress syndrome: a systematic review and network meta-analysis","References":[{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Acute respiratory distress in adults"},{"title3":"Acute respiratory distress syndrome: advances in diagnosis and treatment"},{"title3":"Acute respiratory distress syndrome"},{"title3":"Ventilator-induced lung injury"},{"title3":"An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial"},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome"},{"title3":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit"},{"title3":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis"},{"title3":"GRADE guidelines 6: rating the quality of evidence: imprecision"},{"title3":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis"},{"title3":"GRADE approach to rate the certainty from a network meta-analysis: avoiding spurious judgments of imprecision in sparse networks"},{"title3":"Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales"},{"title3":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis"},{"title3":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence"},{"title3":"Automating network meta-analysis"},{"title3":"Accounting for correlation in network meta-analysis with multi-arm trials"},{"title3":"General methods for monitoring convergence of iterative simulations"},{"title3":"Bayesian measures of model complexity and fit"},{"title3":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial"},{"title3":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials"},{"title3":"High-frequency oscillation in early acute respiratory distress syndrome"},{"title3":"High-frequency oscillation for acute respiratory distress syndrome"},{"title3":"Efficacy and adverse events of early high-frequency oscillatory ventilation in adult burn patients with acute respiratory distress syndrome"},{"title3":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial"},{"title3":"Prone positioning in acute respiratory distress syndrome: a multicenter randomized clinical trial"},{"title3":"Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome"},{"title3":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome"},{"title3":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Mechanical ventilation guided by esophageal pressure in acute lung injury"},{"title3":"Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome"},{"title3":"Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: a multicenter randomized controlled clinical trial"},{"title3":"A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome"},{"title3":"Open lung approach for the acute respiratory distress syndrome: a pilot, randomized controlled trial"},{"title3":"Combined effects of inhaled nitric oxide and a recruitment maneuver in patients with acute respiratory distress syndrome"},{"title3":"Comparison of prone positioning and high-frequency oscillatory ventilation in patients with acute respiratory distress syndrome"},{"title3":"Lung ventilation strategies for acute respiratory distress syndrome: a systematic review and network meta-analysis"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial"},{"title3":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults"},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality: analysis of the extracorporeal life support organization registry"}]},{"title2":"The RECOVER program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation","References":[]},{"title2":"Early neuromuscular blockade in the acute respiratory distress syndrome","References":[{"title3":"Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Ventilator-induced lung injury: from the bench to the bedside"},{"title3":"Ventilator-associated lung injury"},{"title3":"Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Early hepatic dysfunction is associated with a worse outcome in patients presenting with acute respiratory distress syndrome: a post-hoc analysis of the ACURASYS and PROSEVA studies"},{"title3":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome"},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome"},{"title3":"Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure"},{"title3":"Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: a PARDIE study"},{"title3":"Acute lung injury in children: therapeutic practice and feasibility of international clinical trials"},{"title3":"Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*"},{"title3":"Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)"},{"title3":"Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome"},{"title3":"Neuromuscular manifestations of critical illness"},{"title3":"Prospective documentation of sedative, analgesic, and neuromuscular blocking agent use in infants and children in the intensive care unit: a multicenter perspective"},{"title3":"Continuous-infusion neuromuscular blocking agents in critically ill neonates and children"},{"title3":"Allergic risk during paediatric anaesthesia"},{"title3":"ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children"},{"title3":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference"},{"title3":"The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment"},{"title3":"Nonrespiratory pediatric logistic organ dysfunction-2 score is a good predictor of mortality in children with acute respiratory failure"},{"title3":"Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria"},{"title3":"Reproducibility of childhood respiratory symptom questions"},{"title3":"Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm"},{"title3":"Diagnosis and management of critical illness polyneuropathy and critical illness myopathy"},{"title3":"An Evaluation of Various Ventilator-Associated Infection Criteria in a PICU"},{"title3":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests"},{"title3":"Reappraisal of Ventilator-Free Days in Critical Care Research"},{"title3":"Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"The REDCap consortium: Building an international community of software platform partners"},{"title3":"How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children?"},{"title3":"Nonpulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Functional Status Scale: new pediatric outcome measure"},{"title3":"Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies"},{"title3":"Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease"},{"title3":"Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function"},{"title3":"Early life origins of chronic obstructive pulmonary disease"},{"title3":"Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study"},{"title3":"Reduced PICU respiratory admissions during COVID-19"},{"title3":"Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy"}]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]}]},{"title1":"Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO  A single-centre, retrospective observational cohort experience","References":[{"title2":"Clinical feedback from experience with COVID-19: specific considerations for extracorporeal membrane oxygenation","References":[{"title3":"World Health Organization (WHO). Coronavirus disease (COVID-19) outbreak (https://www.who.int). 2020."},{"title3":"Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"The PRESERVE mortality risk score and analysis of long-term outcomes afterextracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"}]},{"title2":"Severe influenza a cases requiring extra-corporeal membrane oxygenation (ECMO) therapy, 2018-2019","References":[]},{"title2":"Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series","References":[{"title3":"Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate"},{"title3":"Chinese expert consensus on supportive treatment of extracorporeal membrane oxygenation novel coronavirus pneumonia"},{"title3":"MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA Published online February 19, 2020. doi:10.1001/jama.2020.2342."},{"title3":"Yang X, Yu Y, Xu J, et al. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. Published online February 21, 2020. doi: 10.1016/S2213-2600(20)30079-5."},{"title3":"Preparing for COVID-19: early experience from an intensive care unit in Singapore"},{"title3":"Diagnosis and treatment guideline for COVID-19 infection (trial version 6) http://www.nhc.gov.cn, Accessed 18 Feb 2020. [in Chinese]."},{"title3":"Mishra V, Svennevig JL, Bugge JF, et al. Cost of extracorporeal membrane oxygenation: evidence from the Rikshospitalet University Hospital, Oslo, Norway. Eur J Cardiothorac Surg. 2010;37(2):339-42. 10.1016/j.ejcts.2009.06.059."}]},{"title2":"Successful treatment of COVID-19 using extracorporeal membrane oxygenation, a case report","References":[{"title3":"Pathological sequelae of long-haul COVID"},{"title3":"Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization"},{"title3":"A case of fulminant myocarditis due to COVID-19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery"},{"title3":"Age-dependent effects in the transmission and control of COVID-19 epidemics"},{"title3":"COVID-19 and myocarditis: a systematic review and overview of current challenges"},{"title3":"Cytokine storm in COVID-19: the current evidence and treatment strategies"},{"title3":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management"},{"title3":"Myocarditis in COVID-19 patients: current problems"},{"title3":"Early initiation of extracorporeal blood purification using the AN69ST (oXiris ) hemofilter as a treatment modality for COVID-19 patients: a single-centre case series"},{"title3":"Myocarditis associated with Covid-19 disease: a systematic review of published case reports and case series"},{"title3":"COVID-19 infection and myocarditis: a state-of-the-art systematic review"},{"title3":"Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England"},{"title3":"Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection"},{"title3":"SARS-CoV-2 reinfection and COVID-19 severity"},{"title3":"COVID-19 reinfection: a rapid systematic review of case reports and case series"},{"title3":"The mystery of COVID-19 reinfections: a global systematic review and meta-analysis"},{"title3":"Current insights into the pathophysiology of multisystem inflammatory syndrome in children"},{"title3":"Similarities and differences between COVID-19-related multisystem inflammatory syndrome in children and kawasaki disease"},{"title3":"Short-term cardiovascular complications of multi-system inflammatory syndrome in children (MIS-C) in adolescents and children"},{"title3":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19"},{"title3":"The importance of myocarditis in Covid-19"},{"title3":"Cardiovascular injury due to SARS-CoV-2"},{"title3":"Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses"},{"title3":"Cytokine storm"},{"title3":"Could SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome?"},{"title3":"First reported use of highly adsorptive hemofilter in critically ill COVID-19 patients in the USA"},{"title3":"Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review"},{"title3":"Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature"},{"title3":"Cytokine removal in human septic shock: where are we and where are we going?"},{"title3":"Continuous hemodiafiltration with the oXiris  filter ameliorates cytokine storm and induces rapid clinical improvement in COVID-19 - a case report"},{"title3":"Successful treatment of a critically ill COVID-19 patient using continuous renal replacement therapy with enhanced cytokine removal and tocilizumab: a case report"},{"title3":"Blood purification in severe and critical COVID-19 patients: a case series of 5 patients"},{"title3":"Continuous renal replacement therapy with oXiris  filter may not be an effective resolution to alleviate cytokine release syndrome in non-AKI patients with severe and critical COVID-19"},{"title3":"Promising therapy for heart failure in patients with severe COVID-19: calming the cytokine storm"},{"title3":"Serum cytokines profile of critically ill COVID-19 patients with cardiac dysfunction"},{"title3":"ECMO in COVID-19 patients: a systematic review and meta-analysis"}]},{"title2":"Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation","References":[]},{"title2":"Extracorporeal membrane oxygenation in coronavirus disease 2019-associated acute respiratory distress syndrome: an initial US experience at a high-volume centre","References":[{"title3":"Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Extracorporeal membrane oxygenation for coronavirus disease 2019 in Shanghai, China"},{"title3":"Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: experience with 32 patients"},{"title3":"WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Geneva: WHO; 2020"},{"title3":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score"}]},{"title2":"Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure","References":[{"title3":"Johns Hopkins University &amp; Medicine-Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed 29 Nov 2020"},{"title3":"Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure"},{"title3":"Saying no until the moment is right: initiating ECMO in the EOLIA era"},{"title3":"Mechanical ventilation for acute respiratory distress syndrome during extracorporeal life support. Research and practice"},{"title3":"Extracorporeal life support for adults with acute respiratory distress syndrome"},{"title3":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"ECMO for severe ARDS: systematic review and individual patient data meta-analysis"},{"title3":"Extracorporeal membrane oxygenation for coronavirus disease 2019 in Shanghai"},{"title3":"Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"The role of extracorporeal life support for patients with COVID-19: preliminary results from a statewide experience"},{"title3":"Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: experience with 32 patients"},{"title3":"Veno-venous extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: early experience from a major academic medical Center in North America"},{"title3":"Extracorporeal membrane oxygenation for critically ill patients with COVID-19 related acute respiratory distress syndrome: worth the effort?"},{"title3":"Extracorporeal membrane oxygenation support in severe COVID-19"},{"title3":"Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study"},{"title3":"Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry"},{"title3":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US"},{"title3":"The REDCap consortium: building an international community of software platform partners"},{"title3":"Advanced pulmonary and cardiac support of COVID-19 patients: emerging recommendations from ASAIO-A &quot;living working document&quot;"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on &quot;sepsis-related problems&quot; of the European Society of Intensive Care Medicine"},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score"},{"title3":"Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study"},{"title3":"Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO"},{"title3":"Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: a systematic review and meta-analysis"},{"title3":"Emulating a novel clinical trial using existing observational data predicting results of the PreVent study"},{"title3":"Avoidable flaws in observational analyses: an application to statins and cancer"},{"title3":"Estimates of overall survival in patients with cancer receiving different treatment regimens: emulating hypothetical target trials in the surveillance, epidemiology, and end results (SEER)-medicare linked database"},{"title3":"Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19"},{"title3":"Administrative database research infrequently used validated diagnostic or procedural codes"},{"title3":"What's new in ECMO for COVID-19?"},{"title3":"Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?"},{"title3":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory Distress Syndrome. An international multicenter prospective cohort"}]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study","References":[{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"Extracorporeal membrane oxygenation for coronavirus disease 2019-induced acute respiratory distress syndrome: a multicenter descriptive study"},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 disease is suspected"},{"title3":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)"},{"title3":"Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: any impact on their outcomes?"},{"title3":"Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective single center cohort study"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Severe pulmonary embolism in COVID-19 patients: a call for increased awareness"},{"title3":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort"},{"title3":"Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine"},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score"},{"title3":"Ventilator-related causes of lung injury: the mechanical power"},{"title3":"Physiologic analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome"},{"title3":"Tutorial in biostatistics: competing risks and multi-state models"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Formal guidelines: management of acute respiratory distress syndrome"},{"title3":"Extracorporeal life support for adults with respiratory failure and related indications: a review"},{"title3":"Driving pressure and survival in the acute respiratory distress syndrome"},{"title3":"Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis"},{"title3":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence"},{"title3":"Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock"}]},{"title2":"Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers","References":[{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response."},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study."},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases."},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome."},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial."},{"title3":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis."},{"title3":"Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)."},{"title3":"Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure."},{"title3":"Joint Society of Critical Care Medicine-Extracorporeal Life Support Organization Task Force position paper on the role of the intensivist in the initiation and management of extracorporeal membrane oxygenation."},{"title3":"Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: A systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO."},{"title3":"Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis."},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus."},{"title3":"Extracorporeal membrane oxygenation in severe ARDS secondary to Middle East respiratory syndrome coronavirus."},{"title3":"Ethics of triage in the event of an influenza pandemic."},{"title3":"Triage: Care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."},{"title3":"Practice patterns and ethical considerations in the management of venovenous extracorporeal membrane oxygenation patients: An international survey."},{"title3":"Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults."},{"title3":"Understanding ethical decisions for patients on extracorporeal life support."},{"title3":"Treatment limitations in the era of ECMO."},{"title3":"Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients."},{"title3":"Position paper for the organization of ECMO programs for cardiac failure in adults."},{"title3":"Preparing for the most critically ill patients with COVID-19: The potential role of extracorporeal membrane oxygenation."},{"title3":"Refining surge capacity: Conventional, contingency, and crisis capacity."},{"title3":"Extracorporeal life support for adults with respiratory failure and related indications: A review."},{"title3":"Covid-19 does not lead to a &quot;Typical&quot; acute respiratory distress syndrome."},{"title3":"COVID-19 pneumonia: Different respiratory treatment for different phenotypes?"},{"title3":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort."},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease."},{"title3":"The variety of cardiovascular presentations of COVID-19."},{"title3":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic."},{"title3":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study."},{"title3":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19."},{"title3":"COVID-19 complicated by acute pulmonary embolism."},{"title3":"Acute pulmonary embolism and COVID-19 pneumonia: A random association?"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19."},{"title3":"Management of refractory cardiogenic shock."},{"title3":"The ELSO Maastricht Treaty for ECLS Nomenclature: Abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization."},{"title3":"In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China."},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score."},{"title3":"Predicting survival after ECMO for refractory cardiogenic shock: The survival after veno-arterial-ECMO (SAVE)-score."},{"title3":"The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome."},{"title3":"The role of echocardiography in the management of patients supported by extracorporeal membrane oxygenation."},{"title3":"Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations."},{"title3":"Preparing for COVID-19: Early experience from an intensive care unit in Singapore."},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection."},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome."},{"title3":"Mechanical ventilation for acute respiratory distress syndrome during extracorporeal life support. Research and practice."},{"title3":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial."},{"title3":"COVID-19: Consider cytokine storm syndromes and immunosuppression."},{"title3":"Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome."},{"title3":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients."},{"title3":"Nutrition therapy in critical illness: A review of the literature for clinicians."},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial."},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19."},{"title3":"Using PK/PD to optimize antibiotic dosing for critically ill patients."},{"title3":"Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock."},{"title3":"Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation."},{"title3":"Sequestration of drugs in the cicuit may lead to therapeutic failure during extracorporeal membrane oxygenation."},{"title3":"Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: Results from an ex vivo study."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Extracorporeal membrane oxygenation and cytokine adsorption."},{"title3":"Early mobilization of patients receiving extracorporeal membrane oxygenation: A retrospective cohort study."},{"title3":"Cannula and circuit management in peripheral extracorporeal membrane oxygenation: An international survey of 45 countries."},{"title3":"How I wean patients from veno-venous extra-corporeal membrane oxygenation."},{"title3":"Weaning from veno-venous extracorporeal membrane oxygenation: How I do it."},{"title3":"Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock."},{"title3":"Safe patient transport for COVID-19."},{"title3":"Incidence of complications in intrahospital transport of critically ill patients-experience in an Austrian university hospital."},{"title3":"Improving the use of personal protective equipment: Applying lessons learned."},{"title3":"Initiation of a new infection control system for the COVID-19 outbreak."},{"title3":"Statement of the UNESCO International Bioethics Committee (IBC) and the UNESCO World Commission on the Ethics of Scientific Knowledge and Technology (COMEST)."}]}]},{"title1":"SARS-CoV-2 Versus Influenza-associated Acute Respiratory Distress Syndrome Requiring Veno-venous Extracorporeal Membrane Oxygenation Support","References":[{"title2":"COVID-19 Pandemic, Situation Update.","References":[{"title3":"Retrospektive Phaseneinteilung der COVID-19- Pandemie in Deutschland bis Februar 2021"},{"title3":"Aktualisierung zur ,,Retrospektiven Phaseneinteilung der COVID-19- Pandemie in Deutsch-land&quot;"},{"title3":"COVID-19-Pandemie: Psychische Storungen werden zunehmen"},{"title3":"Health behaviour and COVID-19: Initial findings on the pandemic"},{"title3":"Developments in the health situation in Germany during the initial stage of the COVID-19 pandemic for selected indicators of GEDA 2019/2020-EHIS"},{"title3":"Gesundheitsmonitoring am Robert Koch-Institut. Sachstand und Perspektiven"},{"title3":"Data Resource Profile: German Health Update (GEDA)-the health interview survey for adults in Germany"},{"title3":"German Health Update (GEDA 2019/2020-EHIS) - Background and methodology"},{"title3":"Fragebogen zur Studie Gesundheit in Deutschland aktuell: GEDA 2019/2020-EHIS"},{"title3":"The PHQ-8 as a measure of current depression in the general population"},{"title3":"Assessment of older people: self-maintaining and instrumental activities of daily living"},{"title3":"Mental health of the adult population in Germany during the COVID-19 pandemic. Rapid Review"},{"title3":"COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults"},{"title3":"Zeitliche Trends beim Rauchverhalten Erwachsener in Deutschland: Ergebnisse sieben bundesweiter Gesundheitssurveys 1991 - 2015"},{"title3":"Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia"},{"title3":"Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain"},{"title3":"The Effects of the Lockdown during the COVID-19 Pandemic on Alcohol and Tobacco Consumption Behavior in Germany"},{"title3":"Self-Reported Alcohol, Tobacco, and Cannabis Use during COVID-19 Lockdown Measures: Results from a Web-Based Survey"},{"title3":"Medizinische Notfalle wahrend der COVID-19-Pandemie"},{"title3":"Notaufnahme wahrend der Coronapandemie: Weniger Non-COVID-19-Notfalle"},{"title3":"Inanspruchnahme deutscher Notaufnahmen wahrend der COVID-19-Pandemie - Der Notaufnahme-Situationsreport (SitRep)"},{"title3":"COVID-19 Pandemic Impact on Decreased Imaging Utilization: A Single Institutional Experience"},{"title3":"The impact of the COVID-19 epidemic on the utilization of emergency dental services"},{"title3":"Decreased utilization of mental health emergency service during the COVID-19 pandemic"},{"title3":"Utilisation of outpatient medical services by people with diagnosed diabetes during the COVID-19 pandemic in Germany"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region, Italy.","References":[]},{"title2":"Guidelines For Adult Respiratory Failure, Version 1.4. Ann Arbor, MI, 2017.","References":[]},{"title2":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports.","References":[{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan"}]},{"title2":"Extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome: Worth the effort?","References":[{"title3":"Extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome: worth the effort? [letter]"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection"},{"title3":"Large dual-lumen extracorporeal membrane oxygenation cannulas are associated with more intracranial hemorrhage"},{"title3":"Direct complications of the Avalon bicaval dual-lumen cannula in respiratory extracorporeal membrane oxygenation (ECMO): single-center experience"},{"title3":"Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Inter Med [online ahead of print] 6 May 2020"},{"title3":"Comparison of the avalon dual-lumen cannula with conventional cannulation technique for venovenous extracorporeal membrane oxygenation"},{"title3":"Driving pressure and survival in the acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"}]},{"title2":"Outcomes of extracorporeal membrane oxygenation support for patients with COVID-19: A pooled analysis of 331 cases.","References":[{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"ECMO in COVID-19 registry"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"}]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: A retrospective cohort study.","References":[{"title3":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study"},{"title3":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary extracorporeal membrane oxygenation providers"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"},{"title3":"Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports"},{"title3":"Extracorporeal membrane oxygenation for coronavirus disease 2019-induced acute respiratory distress syndrome: a multicenter descriptive study"},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 disease is suspected"},{"title3":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)"},{"title3":"Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: any impact on their outcomes?"},{"title3":"Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective single center cohort study"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Severe pulmonary embolism in COVID-19 patients: a call for increased awareness"},{"title3":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort"},{"title3":"Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?"},{"title3":"A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study"},{"title3":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine"},{"title3":"Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score"},{"title3":"Ventilator-related causes of lung injury: the mechanical power"},{"title3":"Physiologic analysis and clinical performance of the ventilatory ratio in acute respiratory distress syndrome"},{"title3":"Tutorial in biostatistics: competing risks and multi-state models"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?"},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Formal guidelines: management of acute respiratory distress syndrome"},{"title3":"Extracorporeal life support for adults with respiratory failure and related indications: a review"},{"title3":"Driving pressure and survival in the acute respiratory distress syndrome"},{"title3":"Mechanical power of ventilation is associated with mortality in critically ill patients: an analysis of patients in two observational cohorts"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis"},{"title3":"Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence"},{"title3":"Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock"}]},{"title2":"Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis.","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Outbreak of a new coronavirus: what anaesthetists should know"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Improved survival rates in patients with H1N1 acute respiratory failure in Korea between 2009 and 2016"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"French legal approach to clinical research"},{"title3":"Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysis"}]},{"title2":"The Berlin definition of ARDS: An expanded rationale, justification, and supplementary material.","References":[]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.","References":[]},{"title2":"Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence.","References":[]},{"title2":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study.","References":[{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP (2020) Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 10.1056/NEJMsb2005114"},{"title3":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 10.1111/jth.14820"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 10.1001/jama.2020.1585"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 10.1111/jth.14860"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy"},{"title3":"Early detection of disseminated intravascular coagulation during septic shock: a multicenter prospective study"},{"title3":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)"},{"title3":"Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation"},{"title3":"Hemostasis and thrombosis in continuous renal replacement treatment"},{"title3":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients"},{"title3":"The endothelium in hypoxic pulmonary vasoconstriction"},{"title3":"Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis"},{"title3":"The stimulation of thrombosis by hypoxia"},{"title3":"Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung"},{"title3":"Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome"},{"title3":"Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome"},{"title3":"Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients"},{"title3":"Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"The pathogenesis of the antiphospholipid syndrome"},{"title3":"High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening"},{"title3":"Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection"},{"title3":"Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS"},{"title3":"Nephrogenic acute respiratory distress syndrome: a narrative review on pathophysiology and treatment"},{"title3":"Multiple roles of the coagulation protease cascade during virus infection"},{"title3":"Molecular pathogenesis of viral hemorrhagic fever"}]},{"title2":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort.","References":[]},{"title2":"Extracorporeal Life Support Organization (ELSO) anticoagulation guidelines. Ann Arbor, MI, 2014.","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury.","References":[]},{"title2":"The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.","References":[{"title3":"Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis"},{"title3":"Self-reported symptoms of depression and memory dysfunction in survivors of ARDS"},{"title3":"Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients"},{"title3":"One-year outcomes in survivors of the acute respiratory distress syndrome"},{"title3":"Functional disability 5 years after acute respiratory distress syndrome"},{"title3":"Survivors of acute respiratory distress syndrome: relationship between pulmonary dysfunction and long-term health-related quality of life"},{"title3":"Extracorporeal membrane oxygenation for respiratory failure in adults"},{"title3":"Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era"},{"title3":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial"},{"title3":"Extracorporeal membrane oxygenation for ARDS in adults"},{"title3":"What is the niche for extracorporeal membrane oxygenation in severe acute respiratory distress syndrome?"},{"title3":"Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a Cohort study and propensity-matched analysis"},{"title3":"Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)"},{"title3":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome"},{"title3":"Extracorporeal life support for severe acute respiratory distress syndrome in adults"},{"title3":"Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"(2000) Acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301-1308"},{"title3":"Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia"},{"title3":"ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life"},{"title3":"Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS"},{"title3":"EOLIA trial, Accessed May 15th, 2013. http://wwwclinicaltrialsgov/ct2/show/NCT01470703?term=eolia&amp;rank=1"},{"title3":"Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults"},{"title3":"Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation"},{"title3":"Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support"},{"title3":"Early percutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery: a randomized trial"},{"title3":"The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation"},{"title3":"The St George's Respiratory Questionnaire"},{"title3":"The hospital anxiety and depression scale"},{"title3":"Impact of Event Scale: a measure of subjective stress"},{"title3":"Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function"},{"title3":"Assessment of older people: self-maintaining and instrumental activities of daily living"},{"title3":"Quality of life after acute respiratory distress syndrome: a meta-analysis"},{"title3":"One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome"},{"title3":"Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study"},{"title3":"Memories and health-related quality of life after intensive care: a follow-up study"},{"title3":"Health-related quality of life and return to work after critical illness in general intensive care unit patients: a 1-year follow-up study"},{"title3":"Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome"},{"title3":"Morbidity, mortality, and quality-of-life outcomes of patients requiring &gt; or = 14 days of mechanical ventilation"},{"title3":"Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock"},{"title3":"Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock"},{"title3":"High-frequency oscillation for acute respiratory distress syndrome"},{"title3":"A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure"},{"title3":"Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange"},{"title3":"The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks"},{"title3":"Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients"},{"title3":"Lung function and quality of life in survivors of the acute respiratory distress syndrome (ARDS)"},{"title3":"Survival, morbidity, and quality of life after discharge from intensive care"},{"title3":"Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"}]},{"title2":"Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: A systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO.","References":[{"title3":"ARDS and influenza A (H1N1): patients' characteristics and management in intensive care unit. A literature review"},{"title3":"A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic"},{"title3":"Extracorporeal life support for pandemic influenza: the role of extracorporeal membrane oxygenation in pandemic management"},{"title3":"Statement of the Director-General of the World Health Organization (10 August 2010). Global Alert and Response: Pandemic (H1N1) 2009"},{"title3":"The rough guide to systematic reviews and meta-analyses"},{"title3":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration"},{"title3":"Meta-analysis and Evidence-based Medicine Training in Cardiology (METCARDIO)"},{"title3":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses"},{"title3":"Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection"},{"title3":"Mobile cardio-respiratory support in prehospital emergency medicine"},{"title3":"French experience of 2009 A/H1N1v influenza in pregnant women"},{"title3":"Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience"},{"title3":"The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand"},{"title3":"Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure"},{"title3":"Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)"},{"title3":"The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks"},{"title3":"Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic"},{"title3":"The 2009 H1N1 influenza outbreak in its historical context"},{"title3":"H1N1: viral pneumonia as a cause of acute respiratory distress syndrome"},{"title3":"Nonventilatory strategies for patients with life-threatening 2009 H1N1 influenza and severe respiratory failure"},{"title3":"Guidelines for Cardiopulmonary Extracorporeal Life Support. Extracorporeal Life Support Organization, Version 1:1. April 2009"},{"title3":"Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study"},{"title3":"Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database"},{"title3":"Extracorporeal membrane oxygenation for acute respiratory distress syndrome: is the configuration mode an important predictor for the outcome?"},{"title3":"Are propensity scores really superior to standard multivariable analysis?"}]},{"title2":"Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: The ECMOnet score.","References":[{"title3":"CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure"},{"title3":"Extracorporeal Membrane Oxygenation for 2009 Influenza A (H1N1) Acute respiratory distress syndrome"},{"title3":"Referral to an extractorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1)"},{"title3":"Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database"},{"title3":"Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection"},{"title3":"The italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks"},{"title3":"Regression analysis for correlated data"},{"title3":"Longitudinal data analysis using generalized linear models"},{"title3":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors"},{"title3":"Akaike's information criterion in generalized estimating equations"},{"title3":"What to do when your hessian is not invertible: alternatives to model respecification in nonlinear estimation"},{"title3":"ROC analysis"},{"title3":"Estimation of the youden index and its associated cutoff point"},{"title3":"Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure"},{"title3":"Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation"},{"title3":"Butt W (2012) Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation"},{"title3":"Is it possible to predict outcome in pulmonary ECMO? analysis of pre-operative risk factors"},{"title3":"Simulation-based training of extracorporeal membrane oxygenation (ECMO) during H1N1 influenza pandemic: the Italian experience"},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome: the acute respiratory distress syndrome network"},{"title3":"Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era"},{"title3":"Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: a case-control study"}]},{"title2":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome.","References":[]},{"title2":"Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1).","References":[]},{"title2":"Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: A cohort study and propensity-matched analysis.","References":[]},{"title2":"COVID-19 Cases on ECMO in the ELSO Registry.","References":[]},{"title2":"Obesity doubles mortality in patients hospitalized for SARS-CoV-2 in Paris hospitals, France: A cohort study on 5795 patients.","References":[]},{"title2":"COVID-19 and ECMO: The interplay between coagulation and inflammation-a narrative review.","References":[{"title3":"https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en. Accessed 3 Apr 2020."},{"title3":"Zhou G, Chen S, Chen Z. Back to the spring of Wuhan: facts and hope of covid-19 outbreak. Front Med. 2020. ahead of print."},{"title3":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS. China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med. 2020."},{"title3":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020. ahead of print."},{"title3":"Mesenchymal stem cells may ameliorate inflammation in an ex vivo model of extracorporeal membrane oxygenation"},{"title3":"ECMO for ARDS: from salvage to standard of care?"},{"title3":"An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome"},{"title3":"Unproven and expensive may still be justifiable"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Li M, Gu SC, Wu XJ, Xia JG, Zhang Y, Zhan QY. Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation. Chin Med J (Engl). 2020. ahead of print."},{"title3":"Lower tidal volume strategy ( 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study"},{"title3":"Ultra-protective ventilation reduces biotrauma in patients on venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal carbon dioxide removal for lowering the risk of mechanical ventilation: research questions and clinical potential for the future"},{"title3":"MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. J Am Med Assoc. 2020. ahead of print."},{"title3":"Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, MacLaren G, Brodie D, Shekar K. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020. ahead of print."},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc. 2020. ahead of print."},{"title3":"Tang X, Du R, Wang R, Cao T, Guan L, Yang C, Zhu Q, Hu M, Li X, Li Y, Liang L, Tong Z, Sun B, Peng P, Shi H. Comparison of hospitalized patients with acute respiratory distress syndrome caused by covid-19 and H1N1. Chest. 2020."},{"title3":"Cytokine storm and sepsis disease pathogenesis"},{"title3":"Pressure and flow properties of cannulae for extracorporeal membrane oxygenation I: return (arterial) cannulae"},{"title3":"Pressure and flow properties of cannulae for extracorporeal membrane oxygenation II: drainage (venous) cannulae"},{"title3":"Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature"},{"title3":"Elevated fibrinogen, von Willebrand factor, and factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women"},{"title3":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology"},{"title3":"Effect of ex vivo extracorporeal membrane oxygenation flow dynamics on immune response"},{"title3":"Severe sepsis and septic shock"},{"title3":"Host-pathogen interactions in sepsis"},{"title3":"The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Hlh Across Speciality Collaboration UK. Covid-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033-1034."},{"title3":"Piacente C, Martucci G, Miceli V, Pavone G, Papeo A, Occhipinti G, Panarello G, Lorusso R, Tanaka K, Arcadipane A. A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: rationale, current use, effects on anticoagulation, and outcomes. Perfusion. 2020:267659120913803. ahead of print."},{"title3":"Antithrombin: anti-inflammatory properties and clinical applications"},{"title3":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. ahead of print."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Interleukin-6 in sepsis and capillary leakage syndrome"},{"title3":"Cytokine reduction in the setting of an ARDS-associated inflammatory response with multiple organ failure"},{"title3":"Extracorporeal membrane oxygenation and cytokine adsorption"},{"title3":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in covid-19: a single center experience. J Med Virol. 2020. ahead of print."},{"title3":"Michot JM, Albiges L, Chaput N, Saada V, Pommeret F, Griscelli F, Balleyguier C, Besse B, Marabelle A, Netzer F, Merad M, Robert C, Barlesi F, Gachot B, Stoclin A. Tocilizumab, an anti-IL6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Ann Oncol. 2020. ahead of print."},{"title3":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020:105954. ahead of print."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Chang LM, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020. ahead of print."},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020. ahead of print."},{"title3":"Cytokine control of megakaryopoiesis"},{"title3":"Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, Liu XY, Liu HM, Guo Z, Ren H, Wang Q. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020. ahead of print."},{"title3":"Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit"},{"title3":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis"},{"title3":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020. ahead of print."},{"title3":"Comparison of coagulation parameters, anticoagulation, and need for transfusion in patients on interventional lung assist or veno-venous extracorporeal membrane oxygenation"},{"title3":"Hemostasis changes during veno-venous extracorporeal membrane oxygenation for respiratory support in adults"},{"title3":"Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study"},{"title3":"Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes"},{"title3":"Comparison of two different minimized extracorporeal circulation systems: hematological effects after coronary surgery"},{"title3":"Platelet function during extracorporeal membrane oxygenation in adult patients: a systematic review"},{"title3":"Ludvigsson JF. Systematic review of covid-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020. ahead of print."},{"title3":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. ahead of print."},{"title3":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest 2020. ahead of print."},{"title3":"Fina D, Matteucci M, Jiritano F, Meani P, Lo Coco V, Kowalewski M, Maessen J, Guazzi M, Ballotta A, Ranucci M, Lorusso R. Extracorporeal membrane oxygenation without therapeutic anticoagulation in adults: a systematic review of the current literature. Int J Artif Organs. 2020:391398820904372. ahead of print."},{"title3":"Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation"},{"title3":"Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ecmo therapy"},{"title3":"Incidence and risk factors for cannula-related venous thrombosis after venovenous extracorporeal membrane oxygenation in adult patients with acute respiratory failure"},{"title3":"Hemorrhagic complications during extracorporeal membrane oxygenation - the role of anticoagulation and platelets"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J. 2020. ahead of print."},{"title3":"Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020. ahead of print."},{"title3":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020."},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. (https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected). Accessed 11 Apr 2020."},{"title3":"United States Center for Disease Control interim guidance for clinical management of COVID-19 patients with and without acute respiratory distress syndrome (https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html). Accessed 11 Apr 2020."},{"title3":"MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA. 2020. ahead of print."},{"title3":"COVID-19, ECMO, and lymphopenia: a word of caution"},{"title3":"EuroElso survey on ECMO use in adult COVID-19 patients in Europe https://www.euroelso.net/covid-19/covid-19-survey. Accessed 11 Apr 2020."}]},{"title2":"Management of early Acute Respiratory Distress Syndrome in adults.","References":[]},{"title2":"Prone positioning in severe acute respiratory distress syndrome.","References":[]},{"title2":"Neuromuscular blockers in early acute respiratory distress syndrome.","References":[]}]},{"title1":"Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19related Acute Respiratory Distress Syndrome: Worth the Effort?","References":[{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","References":[]},{"title2":"Clinical course and outcomes of 344 intensive care patients with COVID-19","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Diagnosis and management of COVID-19 disease [abstract]"},{"title3":"Chinese management guideline for COVID-19 (version 6.0) [in Chinese]"},{"title3":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"Hospital incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition"},{"title3":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Interleukin 2: from immunostimulation to immunoregulation and back again"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"}]},{"title2":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance","References":[]},{"title2":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","References":[]},{"title2":"Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: experience with 32 patients","References":[]},{"title2":"The role of extracorporeal life support for patients with COVID-19: preliminary results from a statewide experience","References":[{"title3":"Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance"},{"title3":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases"},{"title3":"A time to heal: the EMPROVE protocol"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome"},{"title3":"The role of extracorporeal membrane oxygenator therapy in the setting of type A aortic dissection"}]},{"title2":"Traitement anticoagulant pour la prevention du risque thrombotique chez le patient hospitalise avec le COVID-19 et surveillance de l'hemostase, propositions du GIHP et du GHFT","References":[]},{"title2":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","References":[]},{"title2":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","References":[{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP (2020) Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 10.1056/NEJMsb2005114"},{"title3":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 10.1111/jth.14820"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 10.1001/jama.2020.1585"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 10.1111/jth.14860"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity"},{"title3":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"},{"title3":"Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy"},{"title3":"Early detection of disseminated intravascular coagulation during septic shock: a multicenter prospective study"},{"title3":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)"},{"title3":"Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation"},{"title3":"Hemostasis and thrombosis in continuous renal replacement treatment"},{"title3":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients"},{"title3":"The endothelium in hypoxic pulmonary vasoconstriction"},{"title3":"Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis"},{"title3":"The stimulation of thrombosis by hypoxia"},{"title3":"Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung"},{"title3":"Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome"},{"title3":"Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome"},{"title3":"Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients"},{"title3":"Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"The pathogenesis of the antiphospholipid syndrome"},{"title3":"High detection rates of antithrombin deficiency and antiphospholipid syndrome in outpatients aged over 50 years using the standardized protocol for thrombophilia screening"},{"title3":"Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection"},{"title3":"Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS"},{"title3":"Nephrogenic acute respiratory distress syndrome: a narrative review on pathophysiology and treatment"},{"title3":"Multiple roles of the coagulation protease cascade during virus infection"},{"title3":"Molecular pathogenesis of viral hemorrhagic fever"}]}]}]}